These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2474791)
1. Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer. Raymond WA; Leong AS Pathology; 1989 Jan; 21(1):11-5. PubMed ID: 2474791 [TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Bussolati G; Gugliotta P; Morra I; Pietribiasi F; Berardengo E Br J Cancer; 1986 Oct; 54(4):631-6. PubMed ID: 3535864 [TBL] [Abstract][Full Text] [Related]
3. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study. Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997 [TBL] [Abstract][Full Text] [Related]
5. Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins. Sedmak DD; Meineke TA; Knechtges DS Arch Pathol Lab Med; 1989 Jul; 113(7):786-9. PubMed ID: 2472784 [TBL] [Abstract][Full Text] [Related]
6. Expression of retinoblastoma protein in breast cancer metastases to sentinel nodes: evaluation of its role as a marker for the presence of metastases in non-sentinel axillary nodes, and comparison to p16INK4a. Grupka NL; Bloom C; Singh M Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):63-70. PubMed ID: 16540733 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients. Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828 [TBL] [Abstract][Full Text] [Related]
8. Improved detection of metastases to lymph nodes and estrogen receptor determination. Schurman SH; Sharon N; Goldschmidt RA; Scanlon EF Arch Surg; 1990 Feb; 125(2):179-82. PubMed ID: 1689142 [TBL] [Abstract][Full Text] [Related]
9. The immunocytochemical detection of axillary micrometastases in breast cancer. Wells CA; Heryet A; Brochier J; Gatter KC; Mason DY Br J Cancer; 1984 Aug; 50(2):193-7. PubMed ID: 6380553 [TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202 [TBL] [Abstract][Full Text] [Related]
11. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma. Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of micrometastases in axillary lymph nodes in breast carcinoma]. Stosiek P; Gerber B; Kasper M Pathologe; 1996 Nov; 17(6):433-9. PubMed ID: 9082364 [TBL] [Abstract][Full Text] [Related]
13. Chalkley microvessel but not lymphatic vessel density correlates with axillary lymph node metastasis in primary breast cancers. Kanngurn S; Thongsuksai P; Chewatanakornkul S Asian Pac J Cancer Prev; 2013; 14(1):583-7. PubMed ID: 23534799 [TBL] [Abstract][Full Text] [Related]
14. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. den Bakker MA; van Weeszenberg A; de Kanter AY; Beverdam FH; Pritchard C; van der Kwast TH; Menke-Pluymers M J Clin Pathol; 2002 Dec; 55(12):932-5. PubMed ID: 12461062 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Clare SE; Sener SF; Wilkens W; Goldschmidt R; Merkel D; Winchester DJ Ann Surg Oncol; 1997 Sep; 4(6):447-51. PubMed ID: 9309332 [TBL] [Abstract][Full Text] [Related]
16. Breast carcinoma associated with necrotic granulomas in axillary lymph nodes. Sethi S; Carter D Ann Diagn Pathol; 1998 Dec; 2(6):370-6. PubMed ID: 9930574 [TBL] [Abstract][Full Text] [Related]
17. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901 [TBL] [Abstract][Full Text] [Related]
18. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up. Reed W; Bøhler PJ; Sandstad B; Nesland JM Breast J; 2004; 10(3):174-80. PubMed ID: 15125740 [TBL] [Abstract][Full Text] [Related]
19. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results. Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493 [TBL] [Abstract][Full Text] [Related]
20. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry. Kainz C; Gitsch G; Lee A; Danihel L; Breitenecker G Anticancer Res; 1993; 13(1):73-4. PubMed ID: 7682802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]